Succinic semialdehyde dehydrogenase deficiency
(Redirected from SSADH (succinic semialdehyde dehydrogenase deficiency))
Rare autosomal recessive metabolic disorder
Succinic semialdehyde dehydrogenase deficiency | |
---|---|
![]() | |
Synonyms | 4-hydroxybutyric aciduria, Gamma-hydroxybutyric aciduria, SSADH deficiency |
Pronounce | |
Field | Neurology, Medical genetics, Metabolic medicine |
Symptoms | Developmental delay, hypotonia, seizures, ataxia, behavioral disturbances, intellectual disability |
Complications | Neurological impairment, epilepsy, speech and motor deficits |
Onset | Infancy or early childhood |
Duration | Lifelong |
Types | |
Causes | Genetic mutation affecting the ALDH5A1 gene |
Risks | Family history (autosomal recessive inheritance) |
Diagnosis | Genetic testing, urine organic acid analysis, enzymatic assay |
Differential diagnosis | GABA-transaminase deficiency, organic acidurias, other inborn errors of metabolism |
Prevention | Genetic counseling |
Treatment | Supportive management, physical therapy, seizure management |
Medication | Anticonvulsants, pharmacological therapies targeting GABA metabolism |
Prognosis | Variable; typically lifelong neurological impairment |
Frequency | Extremely rare; approximately 450 documented cases worldwide |
Deaths | Rare, mostly due to complications from seizures or associated neurological disorders |
Succinic semialdehyde dehydrogenase deficiency (SSADHD), also known as 4-hydroxybutyric aciduria or Gamma-hydroxybutyric aciduria, is a rare inherited autosomal recessive metabolic disorder characterized by a deficiency of the enzyme succinic semialdehyde dehydrogenase (SSADH). SSADHD deficiency results in the accumulation of gamma-hydroxybutyric acid (GHB) and related substances within the central nervous system, causing various neurological symptoms.
Signs and symptoms[edit | edit source]
Symptoms of SSADH deficiency typically manifest early in infancy or childhood and may include:
- Developmental delay and intellectual disability
- Hypotonia (low muscle tone)
- Ataxia (impaired coordination and balance)
- Seizures and epilepsy
- Behavioral disturbances (hyperactivity, anxiety, aggression)
- Sleep disturbances
- Speech delays or communication deficits
- Movement disorders (e.g., dystonia, tremors)
Severity varies widely among affected individuals.
Causes[edit | edit source]
SSADH deficiency is caused by mutations in the ALDH5A1 gene located on chromosome 6p22. This gene encodes the enzyme succinic semialdehyde dehydrogenase, crucial for the metabolism of the neurotransmitter gamma-aminobutyric acid (GABA).
A deficiency in this enzyme leads to increased GABA and gamma-hydroxybutyric acid (GHB) levels in the brain, disrupting normal neurological function and development.
Pathophysiology[edit | edit source]
Normally, GABA is metabolized into succinic acid by two enzymatic reactions:
- GABA is converted into succinic semialdehyde by GABA-transaminase.
- Succinic semialdehyde is then oxidized to succinic acid by SSADH.
When SSADH is deficient, succinic semialdehyde accumulates and is converted instead to gamma-hydroxybutyric acid (GHB), a compound known to disrupt neuronal signaling, contributing to the neurological symptoms characteristic of this disorder.
Diagnosis[edit | edit source]
Diagnosis typically involves biochemical testing combined with genetic confirmation:
- Urinary organic acid analysis:
- Demonstrates elevated gamma-hydroxybutyric acid (4-hydroxybutyric acid).
- Genetic testing:
- Identifies mutations in the ALDH5A1 gene, confirming the diagnosis.
- Enzyme activity assay:
- Reduced or absent SSADH enzyme activity in fibroblasts or lymphocytes.
Differential diagnosis[edit | edit source]
Conditions that may present similarly and should be ruled out include:
- GABA-transaminase deficiency
- Organic acidurias (e.g., glutaric aciduria, methylmalonic aciduria)
- Mitochondrial disorders
- Other inborn errors of metabolism presenting with neurological symptoms
Treatment[edit | edit source]
Currently, no cure for SSADHD deficiency exists. Treatment is supportive and symptomatic, aimed at improving quality of life:
- Antiepileptic drugs for seizure management.
- Physical therapy and occupational therapy for motor deficits and hypotonia.
- Speech therapy to improve communication abilities.
- Behavioral management and supportive educational programs.
- Pharmacological research is ongoing, with potential future therapies targeting GABA metabolism and neurotransmission.
Prognosis[edit | edit source]
The prognosis is highly variable. Most patients experience lifelong neurological impairment. Intellectual disability and seizures may significantly impact daily life, though supportive care can markedly improve functional outcomes.
Epidemiology[edit | edit source]
SSADHD deficiency is extremely rare, with approximately 450 documented cases worldwide. The true prevalence may be underestimated due to diagnostic challenges.
Genetic counseling[edit | edit source]
As an autosomal recessive condition, there is a 25% chance with each pregnancy that two carrier parents will have an affected child. Genetic counseling is recommended for families with a history of SSADHD deficiency to understand inheritance patterns, recurrence risks, and family planning options.
Research directions[edit | edit source]
Research continues to explore therapies aimed at reducing GHB levels or enhancing SSADH enzyme activity. Clinical trials evaluating novel treatments such as vigabatrin (an irreversible inhibitor of GABA-transaminase) and compounds targeting GABA receptors are ongoing.
See also[edit | edit source]
External links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD